Mucositis and Swallowing Disorders

Mucositis is inflammatory and ulcerative injury of the mucous membranes lining the mouth and gastrointestinal tract, a common toxicity of chemotherapy and radiotherapy. When it affects the mouth, throat, and oesophagus it causes pain and dysphagia (difficulty swallowing), directly impairing the ability to eat and making it a major nutritional concern in cancer and transplant care.

Definition

Mucositis is inflammation and ulceration of the mucosal lining of the alimentary tract caused by cancer therapy; when it involves the oral cavity, pharynx, and oesophagus it produces pain and dysphagia that reduce oral intake and threaten nutritional status.

Scope

The topic covers the nature and pathogenesis of treatment-induced mucositis, how the resulting pain and swallowing difficulty impair intake, and why these problems are central to oncology nutrition. It is a reference overview and does not provide mouth-care protocols, analgesic regimens, or individualized diet prescriptions.

Core questions

• How does cancer treatment injure the mucosal lining and produce mucositis?
• Why do oral and oesophageal mucositis impair eating and swallowing?
• What makes mucositis a central nutritional problem in oncology and transplantation?

Key concepts

• Oral and gastrointestinal mucositis
• Mucosal ulceration and pain
• Dysphagia and odynophagia
• Texture-modified and oral nutrition support
• Radiotherapy- versus chemotherapy-induced mucositis

Mechanisms

Mucositis develops through a sequence of biological events in which chemotherapy or radiation generates tissue injury and reactive oxygen species, activates inflammatory signalling, and leads to epithelial breakdown and ulceration, followed by a healing phase once treatment-related injury subsides. In the mouth, throat, and oesophagus the resulting ulcers cause pain and odynophagia (painful swallowing), so that even soft foods and liquids become difficult, reducing intake at a time when nutritional needs may be increased. This intake barrier is the principal nutritional consequence linking mucositis to malnutrition.

Clinical relevance

Because mucositis can sharply reduce oral intake, it is a recognized trigger for nutritional assessment and support in patients receiving mucotoxic regimens, head and neck radiotherapy, or transplant conditioning. This entry describes the condition for educational reference; oral care, pain management, and any nutritional intervention are individualized and directed by the treating team.

Epidemiology

Mucositis is among the most frequent and burdensome toxicities of cancer therapy, with the highest rates in head and neck radiotherapy, high-dose chemotherapy, and transplant conditioning, where severe oral mucositis is common. It is associated with pain, impaired nutrition, treatment interruptions, and increased risk of infection.

Evidence & guidelines

The MASCC/ISOO clinical practice guidelines (Lalla et al., 2014) summarize the evidence for managing mucositis from cancer therapy, the foundational review by Sonis et al. (2004) describes its pathogenesis, measurement, and consequences, and ESPEN guidance (Arends et al., 2017) situates the nutritional management of intake-limiting toxicities such as mucositis within oncology nutrition.

History

Mucositis was long regarded as simple direct epithelial damage from cytotoxic therapy, but research in the late twentieth and early twenty-first centuries, synthesized by Sonis and colleagues, reframed it as a dynamic, multi-phase biological process involving inflammatory signalling rather than purely mechanical injury, which reshaped how it is measured and studied.

Key figures

• Stephen Sonis
• Rajesh Lalla
• Douglas Peterson
• Dorothy Keefe

Seminal works

• sonis-2004-perspectives
• lalla-2014-mascc

Frequently asked questions

Why does mucositis matter for nutrition rather than just comfort?

Painful ulceration of the mouth, throat, and oesophagus makes swallowing difficult and discouraging, so intake can fall substantially during treatment, which is why mucositis is treated as a nutritional risk and not only a comfort issue.

Is mucositis only a problem in the mouth?

No. Mucositis can affect the lining throughout the gastrointestinal tract; oral and oesophageal mucositis impair eating and swallowing, while injury further down the tract can contribute to diarrhoea and malabsorption.